cholestyramine resin has been researched along with stanozolol in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (stanozolol) | Trials (stanozolol) | Recent Studies (post-2010) (stanozolol) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 580 | 60 | 91 |
| Protein | Taxonomy | cholestyramine resin (IC50) | stanozolol (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.113 | |
| Adenosine receptor A3 | Homo sapiens (human) | 8.325 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 9.274 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 1.1276 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.022 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 8.325 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.048 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 8.325 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kostner, GM | 1 |
1 review(s) available for cholestyramine resin and stanozolol
| Article | Year |
|---|---|
The affection of lipoprotein-a by lipid lowering drugs.
Topics: Arteriosclerosis; Bezafibrate; Cholestyramine Resin; Hormones; Humans; Hypolipidemic Agents; Lipoprotein(a); Lipoproteins; Neomycin; Niacin; Nicotinic Acids; Stanozolol | 1988 |